By ...
9 de August de 2017
Overview of Medicinal product regulation and product liability in Brazil
The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.
The Q&A is part of the global guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-guide.
Share:
Last by ...
15 de May de 2026
CONAR updates Influencers Guide in line with the new requirements for transparency and protection in the digital environment
The National Council for Advertising Self-Regulation (“CONAR”) released, last Monday (11), the new edition of the Guide to Marketing and Advertising by … CONAR updates Influencers Guide in line with the new requirements for transparency and protection in the digital environment
14 de July de 2025
Third edition of “Advertising Law: Year in Review” is now available
The third edition of “Advertising Law: Year in Review”, featuring cases examined by CONAR in 2024, is now available! This publication, prepared … Third edition of “Advertising Law: Year in Review” is now available
5 de July de 2021
Personalised medicine in Brazil: IP and regulatory challenges
Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first … Personalised medicine in Brazil: IP and regulatory challenges